Rafi Emmanuel

Rafi Emmanuel

Company: Emendo Biotherapeutics

Job title: Senior Vice President - Research & Development


Tailormade CRISPR-Based Solutions for Therapeutic Applications 9:00 am

Emendo’s nuclease discovery and protein engineering platforms facilitate the development of the optimal editing strategy for each indication Nucleases with unique PAM sequences allow for targeting exclusive genomic sites Discovery of nucleases of various characteristics enables flexibility in choosing delivery vehiclesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.